Navigation Links
Cypin Production Announces Launch of U.S./China BioPharma Conference:
Date:11/3/2010

PHILADELPHIA, Nov. 2, 2010 /PRNewswire/ -- Cypin Production, a leader in bringing together experts in biopharmaceuticals in the United States and China, is pleased to announce the already-high interest being garnered for its upcoming conference:  "U.S.-CHINA PHARMA: Innovative Strategies and Partnership Models for R&D Success".

The conference, which is scheduled for May 23-24, 2011 at the Hub Cira Centre in Philadelphia, is being chaired by Mikael Dolsten, M.D., Ph.D., President of Worldwide Research & Development (WRD) at Pfizer. A physician with more than 20 years experience in the pharmaceutical industry, Dr. Dolsten oversees thousands of world-class scientists and researchers and understands how important it is for today's U.S. bio-pharma leaders to have strong liaisons with their colleagues in China.

The conference is already off to a strong start, having garnered a renowned speaker faculty. Among the companies whose experts on best practices will be featured: Pfizer Worldwide Research & Development, Merck & Co., Novartis Vaccines & Diagnostics, Abbott Laboratories, Genzyme Transplant and Oncology, LIMR Chemical Genomics Center, the University City Science Center, Crown Bioscience, Bay City Capital, and Safeguard Scientifics, to name just a few.

Among the topics scheduled for this conference are:

  • Comparing China, China's key Asian competitors, and the United States in terms of strengths and weaknesses in pharmaceutical R&D (discovery, preclinical, chemical & formulation, and clinical)
  • Exploring emerging business models and key drivers for U.S.-China Pharma R&D partnerships
  • Important cross-cultural aspects of conducting business activities in China
  • Identifying R&D strategies to cost-effectively expand product portfolios
  • Discussing new strategies to feed R&D pipeline through academic/industry partnerships
  • Examining the role of technology transfer and licensing, and assess potential investment opportunities

Early-bird registration is already available. For fees, to register, and to keep abreast of updated information, check into this website: http://www.chinarndpartnership.com

Media: For comments/additional information on this conference, or on U.S./China biopharma in general, contact Judy Tsui (Twee). Email: judy@cypinproduction.com or phone: 917-338-7778.  


'/>"/>
SOURCE Cypin Production
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Replidynes Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile
2. New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production
3. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
4. Increasing Dairy Milk Production with Electrolyzed Drinking Water
5. Pew Commission Says Industrial Scale Farm Animal Production Poses Unacceptable Risks to Public Health, Environment
6. Wacker Validates Scalability of Anticalin(R) Production With E.coli Secretion Technology and Will Produce Pieris First Clinical Candidate PRS-050
7. Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter
8. Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network
9. DSM and LibraGen Sign Agreement to Co-Develop Transaminases for Production of Chiral Amines
10. FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder
11. Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... LONDON , January 19, 2017 Incretin ... Sympathomimetics and Others The global anti-obesity drugs ... the first half of the forecast period and CAGR of 38.7% ... expected to grow at a CAGR of 32.8% from 2016 to ... million in 2021, and $24,063 million in 2027. ...
(Date:1/19/2017)... Jan. 19, 2017  Sensus Healthcare, Inc. (NASDAQ: ... specializing in the treatment of non-melanoma skin cancers ... superficial radiation therapy, today announced that it will ... financial results on Thursday, February 2, 2017 after the ... a conference call with the investment community on Thursday, ...
(Date:1/19/2017)... LONDON , January 19, 2017 ... New Therapeutic Option to Address Motor Symptoms and ... ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) ... Fabrizio Stocchi , European Neurological Review,2016;11(Suppl. 2): 2-15, ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... 19, 2017 , ... In 2009, Carol Bryan endured immense ... severe facial disfiguration. After four frightening years of isolation and emotional and physical ... who removed the substances in a partial facial transplant through eight surgeries. ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... panel system. , The Tranquility privacy panel system was designed to deliver ... Tranquility panels help reduce noise and provide the visual privacy required to maintain ...
(Date:1/19/2017)... ... January 19, 2017 , ... Sam & Associates Insurance ... commercial and residential clients in the California Bay Area, is launching a charity drive ... the region. , Heart disease is the primary killer of adult men and women ...
(Date:1/19/2017)... ... January 19, 2017 , ... For the ... Lawrenceville, New Jersey and the surrounding area, is inaugurating a charity event ... more commonly known as Lou Gehrig's disease or motor neurone disease, is a ...
(Date:1/19/2017)... ... January 19, 2017 , ... Creative messages ... Real Impact contest from Impact Teen Drivers and California Casualty. Entries from students ... , Educational grants totaling $15,000 will be awarded for the best peer-to-peer messages ...
Breaking Medicine News(10 mins):